VECTUS BIOSYSTEMS LTD has a total of 128 patent applications. It decreased the IP activity by 96.0%. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are GUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD, SYNTHON IP INC and CALICO LIFE SCIENCES LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 12 | |
#2 | United States | 12 | |
#3 | Canada | 10 | |
#4 | Israel | 10 | |
#5 | Australia | 8 | |
#6 | Brazil | 8 | |
#7 | China | 7 | |
#8 | Republic of Korea | 7 | |
#9 | Mexico | 7 | |
#10 | New Zealand | 7 | |
#11 | WIPO (World Intellectual Property Organization) | 7 | |
#12 | Philippines | 5 | |
#13 | Singapore | 5 | |
#14 | South Africa | 5 | |
#15 | Hong Kong | 4 | |
#16 | Russian Federation | 4 | |
#17 | African Regional Industrial Property Organization | 2 | |
#18 | Argentina | 2 | |
#19 | Japan | 2 | |
#20 | Ukraine | 2 | |
#21 | Malaysia | 1 | |
#22 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Heterocyclic compounds | |
#5 | Peptides | |
#6 | Organic chemistry methods | |
#7 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Duggan Karen Annette | 93 |
#2 | Karen Annette Duggan | 15 |
#3 | Lakshman Marshnil | 8 |
#4 | Kaye Anthony | 8 |
#5 | Quazi Nurul | 8 |
#6 | Feast George | 8 |
#7 | Annette Duggan Karen | 2 |
#8 | Duggan Karen A | 1 |
#9 | Winkler David Alan | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018053587A1 | Compositions for the treatment of hypertension and/or fibrosis | |
CN110234631A | For treating the composition of hypertension and/or fibrosis | |
SG11201900182PA | Compositions for the treatment of pulmonary fibrosis | |
CN108349872A | The synthesis of terphenyl compounds | |
EP3271326A1 | Compositions for the treatment of kidney and/or liver disease | |
WO2016145479A1 | Compositions for the treatment of fibrosis and fibrosis-related conditions | |
UA118111C2 | Compositions for the treatment of hypertension and/or fibrosis | |
MX2016003372A | Compositions for the treatment of hypertension and/or fibrosis. | |
EP2349320A1 | Compositions and methods for treatment of kidney disorders | |
EP2783697A2 | VIP Fragments and uses thereof | |
NZ552130A | Compositions and methods for the treatment of cardiovascular disease |